{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:46:31Z","timestamp":1793353591205,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-023-01609-8","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T09:02:17Z","timestamp":1683363737000},"page":"2047-2052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Morbid obesity increases the failure rate of sentinel lymph node mapping for endometrial carcinoma"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9215-5226","authenticated-orcid":false,"given":"Lynette","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"key":"1609_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2017.05.027","volume":"146","author":"RW Holloway","year":"2017","unstructured":"Holloway RW, Abu-Rustum NR, Backes FJ, Boggess JF, Gotlieb WH, Lowery WJ, Rossi EC, Wolsky RJ (2017) Sentinel lymph node mapping and staging in endometrial cancer: a society of gynecologic oncology literature review with consensus recommendations. Gynecol Oncol 146:405\u2013415. https:\/\/doi.org\/10.1016\/j.ygyno.2017.05.027","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1609_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/IGC.0000000000000959","volume":"27","author":"AGZ Eriksson","year":"2017","unstructured":"Eriksson AGZ, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Roche KL, Sonoda Y, Leitao MM, Jewel EL (2017) A comparison of the detection of sentinel lymph nodes using indocyanine green and near-infrared fluorescence imaging versus blue dye during robotic surgery in uterine cancer. Int J Gynecol Cancer 27(4):743\u2013747. https:\/\/doi.org\/10.1097\/IGC.0000000000000959","journal-title":"Int J Gynecol Cancer"},{"key":"1609_CR3","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ygyno.2015.06.024","volume":"138","author":"EJ Tanner","year":"2015","unstructured":"Tanner EJ, Sinno AK, Stone RL, Levinson KL (2015) Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. Gynecol Oncol 138:542\u2013547. https:\/\/doi.org\/10.1016\/j.ygyno.2015.06.024","journal-title":"Gynecol Oncol"},{"key":"1609_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ygyno.2014.05.022","volume":"134","author":"AK Sinno","year":"2014","unstructured":"Sinno AK, Fader AN, Roche KL, Giuntoli RL II, Tanner EJ (2014) A comparison of colorimetric versus fluorometric sentinel lymph node mapping during robotic surgery for endometrial cancer. Gynecol Oncol 134:281\u2013286. https:\/\/doi.org\/10.1016\/j.ygyno.2014.05.022","journal-title":"Gynecol Oncol"},{"key":"1609_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ygyno.2019.03.103","volume":"153","author":"A Rozenholc","year":"2019","unstructured":"Rozenholc A, Samouelian V, Warkus T, Gauthier P, Provencher D, Sauthier P, Gauthier F, Drakopoulos P, Cormier B (2019) Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer. Gynecol Oncol 153:500\u2013504. https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.103","journal-title":"Gynecol Oncol"},{"key":"1609_CR6","doi-asserted-by":"publisher","DOI":"10.1159\/000496699","author":"MM Ianieri","year":"2019","unstructured":"Ianieri MM, Puppo A, Novelli A, Campolo F, Staniscia T, Di Martino G, Piovano E, Bruni F, Roviglione G, Mautone D, Ceccaroni M (2019) Sentinel lymph node biopsy in the treatment of endometrial cancer: why we fail? Results of a prospective multicenter study on the factors associated with failure of node mapping with indocyanine green. Gynecol Obstet Invest. https:\/\/doi.org\/10.1159\/000496699","journal-title":"Gynecol Obstet Invest"},{"key":"1609_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/GCO.0000000000000606","volume":"32","author":"MC Liu","year":"2020","unstructured":"Liu MC, Gardner AB, Wolford JE, Tewari KS (2020) Endometrial cancer in the morbidly obese: a review. Curr Opin Obstet Gynecol 32:42\u201350. https:\/\/doi.org\/10.1097\/GCO.0000000000000606","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1609_CR8","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PG, The Australian National Endometrial Cancer Study Group, Strom BL, Spurdel AB, Soslow RA, Shu X, Schairer C, Sacerdlte C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCoullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey Jyr JV, Kolonel LN, Henderson BE, Hankinson SE, Hakansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Griedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Gernstein L, Anderson K, Anton-Culver H, Horn-Ross SL, PL, (2013) Type I and Type II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607\u20132618. https:\/\/doi.org\/10.1200\/JCO.2012.48.2596","journal-title":"J Clin Oncol"},{"key":"1609_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ajog.2016.11.1033","volume":"216","author":"AJB Smith","year":"2017","unstructured":"Smith AJB, Fader AN, Tanner EJ (2017) Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 216:459\u2013476. https:\/\/doi.org\/10.1016\/j.ajog.2016.11.1033","journal-title":"Am J Obstet Gynecol"},{"key":"1609_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ygyno.2018.06.001","volume":"150","author":"N Body","year":"2018","unstructured":"Body N, Gergoire J, Renaud MC, Sebastianelli A, Grondin K, Plante M (2018) Tips and tricks to improve sentinel lymph node mapping with indocaynin green in endometrial cancer. Gynecol Oncol 150:267\u2013273. https:\/\/doi.org\/10.1016\/j.ygyno.2018.06.001","journal-title":"Gynecol Oncol"},{"issue":"8","key":"1609_CR11","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1245\/s10434-016-5134-2","volume":"23","author":"AGZ Eriksson","year":"2016","unstructured":"Eriksson AGZ, Montovano M, Beavis A, Soslow RA, Zhou Q, Abu-Rustum NR, Gardner GJ, Zivanovic O, Barakat RR, Brown CL, Levine DA, Sonoda Y, Leitao MM, Jewell EL (2016) Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery. Ann Surg Oncol 23(8):2522\u20132528. https:\/\/doi.org\/10.1245\/s10434-016-5134-2","journal-title":"Ann Surg Oncol"},{"key":"1609_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ygyno.2019.03.252","volume":"153","author":"FJ Backes","year":"2019","unstructured":"Backes FJ, Cohen D, Salani R, Cohn DE, O\u2019Malley FE, Suarez AA, Fowler JM (2019) Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Gynecol Oncol 153:496\u2013499. https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.252","journal-title":"Gynecol Oncol"},{"key":"1609_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ygyno.2022.03.003","volume":"165","author":"V Vargui","year":"2022","unstructured":"Vargui V, Rosati A, Capozzi VA, Sozzi G, Gioe A, Berretta R, Chiantera V, Scambia G, Fanfani F, Cosentino F (2022) Impact of obesity on sentinel lymph node mapping in patients with apparent early-stage endometrial cancer: the ObeLyX study. Gynecol Oncol 165:215\u2013222. https:\/\/doi.org\/10.1016\/j.ygyno.2022.03.003","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-023-01609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-023-01609-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-023-01609-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T05:08:52Z","timestamp":1694236132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-023-01609-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1609"],"URL":"https:\/\/doi.org\/10.1007\/s11701-023-01609-8","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Crouse Health Institutional Review Board documents were reviewed and approved via expedited review under category 5 of the Federal regulations (45 CFR 46.110 and 21 CFR 56.110) on 10\/14\/2019. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As a retrospective review with no more than minimal risk to subjects, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}